SCHEMBL26083030

SCHEMBL26083030

CC1(C)CC(C(=O)OCCOC(=O)C(I)c2ccccc2)CC(C)(C)N1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.41
LMNA P02545 4/20 0.40
KDM4E B2RXH2 3/20 0.37
GAA P10253 2/20 0.36
HTT P42858 1/20 0.36
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
HPGD P15428 2/20 0.35
CHRM2 P08172 4/20 0.34
CHRM1 P11229 4/20 0.34
CHRM3 P20309 4/20 0.34
TSHR P16473 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP3A4 P08684 1/20 0.34
CASP1 P29466 1/20 0.34
CHRM4 P08173 2/20 0.34
KMT2A Q03164 3/20 0.33
NR1I2 O75469 1/20 0.33
ABCB11 O95342 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26083181 0.87 CYP2D6 (0.40) CYP2D6LMNAKDM4EGAAHTT
SCHEMBL26083020 0.86 CYP2D6 (0.43) CYP2D6LMNAKDM4EGAAHTT
SCHEMBL26083183 0.77 SLC18A2 (0.34) CYP2D6LMNAGAAHTTALDH1A1
SCHEMBL26083130 0.76 CYP2D6 (0.43) CYP2D6LMNAGAAHTTALDH1A1
SCHEMBL20016522 0.76 HPGD (0.48) GAAHTTALDH1A1SMN1; SMN2HPGD
SCHEMBL20448444 0.76 CHRM1 (0.47) CYP2D6LMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL16710259 0.74 GAA (0.33) CYP2D6KDM4EGAAHTTALDH1A1
SCHEMBL18770956 0.72 GAA (0.32) GAAHTT
SCHEMBL17740426 0.72 EPHX2 (0.34) CYP2D6KDM4EGAAHTTALDH1A1
SCHEMBL26083150 0.71 POLB (0.51) CYP2D6LMNAKDM4EGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11782343-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11782343-B2 Resist composition and patterning process HNRNPU, CBR1, CBR3 CYP2D6 1322/4885LMNA 2948/4885KDM4E 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.